ARCHIVES

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Summarizes AIDS Virus Developments

May 4, 1984

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001